We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Series C round grosses $65mm for aesthetics company Sientra
11 May 2012
Executive Summary
New investor Abingworth Management led a $65mm Series C financing for Sientra Inc. (implantable devices for cosmetic and reconstructive surgery). Returning shareholders also joined, including Clarus Ventures and OrbiMed Advisors. The money will support marketing activities for the company’s Silimed portfolio of silicone gel breast implants, approved by the FDA in early March.
Deal Industry
Medical Devices
Medical Devices
Implantable Devices
Deal Status
Final
Deal Type
Financing
Venture Financing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?